Cited by

• MCMV Dissemination from Latently-Infected Allografts Following Transplantation into Pre-Tolerized Recipients.

  Shah S, DeBerge M, Iovane A, Yan S, Qiu L, Wang JJ, Kanwar YS, Hummel M, Zhang ZJ, Abecassis MM, Luo X, Thorp EB. Shah S, et al. Pathogens. 2020 Jul 26;9(8):607. doi: 10.3390/pathogens9080607. Pathogens. 2020. PMID: 32722544 Free PMC article.
• Uncover diagnostic immunity/hypoxia/ferroptosis/epithelial mesenchymal transformation-related CCR5, CD86, CD8A, ITGAM, and PTPRC in kidney transplantation patients with allograft rejection.

  He L, Wang B, Wang X, Liu Y, Song X, Zhang Y, Li X, Yang H. He L, et al. Ren Fail. 2022 Dec;44(1):1850-1865. doi: 10.1080/0886022X.2022.2141648. Ren Fail. 2022. PMID: 36330810 Free PMC article.
• Polyomavirus BK Induces Inflammation via Up-regulation of CXCL10 at Translation Levels in Renal Transplant Patients with Nephropathy.

  Kariminik A, Dabiri S, Yaghobi R. Kariminik A, et al. Inflammation. 2016 Aug;39(4):1514-9. doi: 10.1007/s10753-016-0385-4. Inflammation. 2016. PMID: 27277862
• Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection.

  Haskell CA, Hancock WW, Salant DJ, Gao W, Csizmadia V, Peters W, Faia K, Fituri O, Rottman JB, Charo IF. Haskell CA, et al. J Clin Invest. 2001 Sep;108(5):679-88. doi: 10.1172/JCI12976. J Clin Invest. 2001. PMID: 11544273 Free PMC article.
• Specialized Roles of Human Natural Killer Cell Subsets in Kidney Transplant Rejection.

  Kildey K, Francis RS, Hultin S, Harfield M, Giuliani K, Law BMP, Wang X, See EJ, John G, Ungerer J, Wilkinson R, Kassianos AJ, Healy H. Kildey K, et al. Front Immunol. 2019 Aug 7;10:1877. doi: 10.3389/fimmu.2019.01877. eCollection 2019. Front Immunol. 2019. PMID: 31440252 Free PMC article.